| mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.007 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
Epothilone B |
FIMM |
pan-cancer |
AAC |
0.018 |
0.9 |
| mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |